The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Pulmonary Circulation

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Pulmonary Circulation


High impact information on Pulmonary Circulation


Chemical compound and disease context of Pulmonary Circulation


Biological context of Pulmonary Circulation


Anatomical context of Pulmonary Circulation


Associations of Pulmonary Circulation with chemical compounds


Gene context of Pulmonary Circulation


Analytical, diagnostic and therapeutic context of Pulmonary Circulation


  1. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. Adnot, S., Raffestin, B., Eddahibi, S., Braquet, P., Chabrier, P.E. J. Clin. Invest. (1991) [Pubmed]
  2. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Yoshibayashi, M., Nishioka, K., Nakao, K., Saito, Y., Matsumura, M., Ueda, T., Temma, S., Shirakami, G., Imura, H., Mikawa, H. Circulation (1991) [Pubmed]
  3. Endothelin production in pulmonary circulation of patients with mitral stenosis. Yamamoto, K., Ikeda, U., Mito, H., Fujikawa, H., Sekiguchi, H., Shimada, K. Circulation (1994) [Pubmed]
  4. Binding of charged ferritin to alveolar wall components and charge selectivity of macromolecular transport in permeability pulmonary edema in rats. Brody, J.S., Vaccaro, C.A., Hill, N.S., Rounds, S. Circ. Res. (1984) [Pubmed]
  5. Effects of the converting enzyme inhibitor (SQ 20881) on the pulmonary circulation in man. Niarchos, A.P., Roberts, A.J., Laragh, J.H. Am. J. Med. (1979) [Pubmed]
  6. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. Dinh-Xuan, A.T., Higenbottam, T.W., Clelland, C.A., Pepke-Zaba, J., Cremona, G., Butt, A.Y., Large, S.R., Wells, F.C., Wallwork, J. N. Engl. J. Med. (1991) [Pubmed]
  7. The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. Fagan, K.A., Fouty, B.W., Tyler, R.C., Morris, K.G., Hepler, L.K., Sato, K., LeCras, T.D., Abman, S.H., Weinberger, H.D., Huang, P.L., McMurtry, I.F., Rodman, D.M. J. Clin. Invest. (1999) [Pubmed]
  8. Effects of chronic hypoxia and altered hemodynamics on endothelial nitric oxide synthase expression in the adult rat lung. Le Cras, T.D., Tyler, R.C., Horan, M.P., Morris, K.G., Tuder, R.M., McMurtry, I.F., Johns, R.A., Abman, S.H. J. Clin. Invest. (1998) [Pubmed]
  9. Oxygen-induced constriction of rabbit ductus arteriosus occurs via inhibition of a 4-aminopyridine-, voltage-sensitive potassium channel. Tristani-Firouzi, M., Reeve, H.L., Tolarova, S., Weir, E.K., Archer, S.L. J. Clin. Invest. (1996) [Pubmed]
  10. Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen. Liao, J.K., Zulueta, J.J., Yu, F.S., Peng, H.B., Cote, C.G., Hassoun, P.M. J. Clin. Invest. (1995) [Pubmed]
  11. Dithionite increases radical formation and decreases vasoconstriction in the lung. Evidence that dithionite does not mimic alveolar hypoxia. Archer, S.L., Hampl, V., Nelson, D.P., Sidney, E., Peterson, D.A., Weir, E.K. Circ. Res. (1995) [Pubmed]
  12. Pulmonary vasoconstrictor overreactivity in borderline systemic hypertension. Moruzzi, P., Sganzerla, P., Guazzi, M.D. Cardiovasc. Res. (1989) [Pubmed]
  13. Decreased arterial wall prostaglandin production in neonatal calves with severe chronic pulmonary hypertension. Badesch, D.B., Orton, E.C., Zapp, L.M., Westcott, J.Y., Hester, J., Voelkel, N.F., Stenmark, K.R. Am. J. Respir. Cell Mol. Biol. (1989) [Pubmed]
  14. Adenosine plasma concentration in pulmonary hypertension. Saadjian, A.Y., Paganelli, F., Gaubert, M.L., Levy, S., Guieu, R.P. Cardiovasc. Res. (1999) [Pubmed]
  15. Degradation of porstaglandin F2alpha in the human pulmonary circulation. Jose, P., Niederhauser, U., Piper, P.J., Robinson, C., Smith, A.P. Thorax (1976) [Pubmed]
  16. Adenosine as a vasodilator in primary pulmonary hypertension. Morgan, J.M., McCormack, D.G., Griffiths, M.J., Morgan, C.J., Barnes, P.J., Evans, T.W. Circulation (1991) [Pubmed]
  17. Serotonin transport by cultured bovine aortic endothelium. Shepro, D., Batbouta, J.C., Robblee, L.S., Carson, M.P., Belamarich, F.A. Circ. Res. (1975) [Pubmed]
  18. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. Ghofrani, H.A., Voswinckel, R., Reichenberger, F., Olschewski, H., Haredza, P., Karadaş, B., Schermuly, R.T., Weissmann, N., Seeger, W., Grimminger, F. J. Am. Coll. Cardiol. (2004) [Pubmed]
  19. Dietary salt supplementation selectively downregulates NPR-C receptor expression in kidney independently of ANP. Sun, J.Z., Chen, S.J., Majid-Hasan, E., Oparil, S., Chen, Y.F. Am. J. Physiol. Renal Physiol. (2002) [Pubmed]
  20. Prolonged infusions of estradiol dilate the ovine fetal pulmonary circulation. Parker, T.A., Kinsella, J.P., Galan, H.L., Le Cras, T.D., Richter, G.T., Markham, N.E., Abman, S.H. Pediatr. Res. (2000) [Pubmed]
  21. Oral prostaglandin E2 in ductus-dependent pulmonary circulation. Silove, E.D., Coe, J.Y., Shiu, M.F., Brunt, J.D., Page, A.J., Singh, S.P., Mitchell, M.D. Circulation (1981) [Pubmed]
  22. cAMP response element-binding protein content is a molecular determinant of smooth muscle cell proliferation and migration. Klemm, D.J., Watson, P.A., Frid, M.G., Dempsey, E.C., Schaack, J., Colton, L.A., Nesterova, A., Stenmark, K.R., Reusch, J.E. J. Biol. Chem. (2001) [Pubmed]
  23. The requirement of intercellular adhesion molecule-1 for neutrophil respiratory burst in the pulmonary circulation of rats infused with endotoxin. Minamiya, Y., Motoyama, S., Kitamura, M., Saito, S., Terada, K., Ogawa, J. Am. J. Respir. Crit. Care Med. (1998) [Pubmed]
  24. Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Rabiller, A., Nunes, H., Lebrec, D., Tazi, K.A., Wartski, M., Dulmet, E., Libert, J.M., Mougeot, C., Moreau, R., Mazmanian, M., Humbert, M., Hervé, P. Am. J. Respir. Crit. Care Med. (2002) [Pubmed]
  25. Autonomic control of cardiovascular performance and whole body O2 delivery and utilization in swine during treadmill exercise. Stubenitsky, R., Verdouw, P.D., Duncker, D.J. Cardiovasc. Res. (1998) [Pubmed]
  26. Pulmonary hypertension, anorexigens and 5-HT: pharmacological synergism in action? MacLean, M.R. Trends Pharmacol. Sci. (1999) [Pubmed]
  27. Unusual pulmonary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with endoperoxides and other prostanoids. Hyman, A.L., Chapnick, B.M., Kadowitz, P.J., Lands, W.E., Crawford, C.G., Fried, J., Barton, J. Proc. Natl. Acad. Sci. U.S.A. (1977) [Pubmed]
  28. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Celermajer, D.S., Cullen, S., Deanfield, J.E. Circulation (1993) [Pubmed]
  29. Parameters of pulmonary injury after total or partial cardiopulmonary bypass. Friedman, M., Sellke, F.W., Wang, S.Y., Weintraub, R.M., Johnson, R.G. Circulation (1994) [Pubmed]
  30. BQ123, an ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells. Zamora, M.A., Dempsey, E.C., Walchak, S.J., Stelzner, T.J. Am. J. Respir. Cell Mol. Biol. (1993) [Pubmed]
  31. Receptor- and non-receptor-mediated clearance of big-endothelin and endothelin-1: differential effects of acute and chronic ETA receptor blockade. Burkhardt, M., Barton, M., Shaw, S.G. J. Hypertens. (2000) [Pubmed]
  32. Deletion of the eNOS gene has a greater impact on the pulmonary circulation of male than female mice. Miller, A.A., Hislop, A.A., Vallance, P.J., Haworth, S.G. Am. J. Physiol. Lung Cell Mol. Physiol. (2005) [Pubmed]
  33. Developmental expression of vasoactive and growth factors in human lung. Role in pulmonary vascular resistance adaptation at birth. Lévy, M., Maurey, C., Dinh-Xuan, A.T., Vouhé, P., Israël-Biet, D. Pediatr. Res. (2005) [Pubmed]
  34. Endothelin receptor subtypes in human versus rabbit pulmonary arteries. Fukuroda, T., Kobayashi, M., Ozaki, S., Yano, M., Miyauchi, T., Onizuka, M., Sugishita, Y., Goto, K., Nishikibe, M. J. Appl. Physiol. (1994) [Pubmed]
  35. A new experimental model for measurement of pulmonary arterial haemodynamic variables in conscious rats before and after pulmonary embolism and during general anaesthesia. Riegger, G.A., Hoferer, P. Cardiovasc. Res. (1990) [Pubmed]
  36. Alterations in atrial and plasma atrial natriuretic factor (ANF) content during development of hypoxia-induced pulmonary hypertension in the rat. McKenzie, J.C., Tanaka, I., Inagami, T., Misono, K.S., Klein, R.M. Proc. Soc. Exp. Biol. Med. (1986) [Pubmed]
  37. Atrial natriuretic factor recognizes two receptor subtypes in endothelial cells cultured from bovine pulmonary artery. Redmond, E.M., Cahill, P.A., Keenan, A.K. FEBS Lett. (1990) [Pubmed]
  38. Non-invasive assessment of technetium-99m albumin transit time distribution in the pulmonary circulation by first-pass angiocardiography. Capderou, A., Douguet, D., Similowski, T., Aurengo, A., Zelter, M. European journal of nuclear medicine. (1997) [Pubmed]
WikiGenes - Universities